Coronavirus (COVID-19) Resource Center

Below is a list of articles related to vaccines, and updated regularly:
 

Click here for older articles

• Dutcher E, et al. "COVID-19 Vaccine Side Effects and Long-Term Neutralizing Antibody Response: A Prospective Cohort Study." Annals of Internal Medicine 11 June 2024 https://doi.org/10.7326/M23-2956. 
   

• Hammond J, et al. "Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19." April 3, 2024 N Engl J Med 2024;390:1186-1195 https://doi.org/10.1056/NEJMoa2309003 VOL. 390 NO. 13 
   

• Thompson M.G., et al. "Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines." February 22, 2024 N Engl J Med 2024; 390:772 https://doi.org/10.1056/NEJMx210021. 
   

• Ali S, et al. "Anti-Melanoma Differentiation-Associated Protein-5 and Anti-Polymyositis/Scl-75 Antibody-Associated Interstitial Lung Disease Triggered by COVID-19 Vaccine: A Case Report." Annals of Internal Medicine: Clinical CasesVolume 3, Issue 2 published February 06, 2024 https://doi.org/10.7326/aimcc.2023.0652. 
   

• Kanai M, et al. "Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial." Lancet Infect Dis. 2023 Dec 20 doi: 10.1016/S1473-3099(23)00650-3. 
   

• Zhou J, et al. "Post–COVID-19 Vaccine Myopericarditis in a Transgender Man Undergoing Gender-Affirming Testosterone Therapy." Annals of Internal Medicine: Clinical CasesVolume 3, Issue 1 January 2024. https://doi.org/10.7326/aimcc.2023.0544 January 16, 2024  
   

• Valdes Y, et al. "COVID-19 Vaccination and Reproductive Health: a Comprehensive Review for Healthcare Providers." Reprod. Sci. (2023). https://doi.org/10.1007/s43032-023-01428-0 Published: 27 December 2023.
   

• Kuhn T, et al. "Evaluating the impact of short animated videos on COVID-19 vaccine hesitancy: An online randomized controlled trial." Internet Interventions, Volume 35, 2024, https://doi.org/10.1016/j.invent.2023.100694. Available online 1 December 2023.
   

• Liu X, et al. "Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial." Lancet Respir Med. 2023 Dec;11(12):1075-1088. https://doi.org/10.1016/S2213-2600(23)00349-1. Epub 2023 Nov 15. 
   

• Chi H, et al. "The Effectiveness of Bivalent COVID-19 Vaccination: A Preliminary Report." Life (Basel). 2023 Oct 21;13(10):2094. https://doi.org/10.3390/life13102094. 
   

• Chi H, et al. "The Effectiveness of Bivalent COVID-19 Vaccination: A Preliminary Report." Life (Basel). 2023 Oct 21;13(10):2094. https://doi.org/10.3390/life13102094. (Systematic review) 
   

• Weng ZY, et al. "Immunogenicity and effectiveness of COVID-19 booster vaccination among people living with HIV: a systematic review and meta-analysis." Front Med (Lausanne). 2023 Oct 9;10:1275843. https://doi.org/10.3389/fmed.2023.1275843. eCollection 2023. 
   

• Lepage C, et al. "Persuasive COVID-19 vaccination campaigns on Facebook and nationwide vaccination coverage in Ukraine, India, and Pakistan." PLOS Glob Public Health. 2023 Sep 27;3(9):e0002357.  https://doi.org/10.1371/journal.pgph.0002357. eCollection 2023. 
   

• Manothummetha K, et al. "Attenuated immunogenicity of SARS-CoV-2 vaccines and risk factors in stem cell transplant recipients: a meta-analysis." Blood Adv. 2023 Sep 26;7(18):5624-5636. https://doi.org/10.1182/bloodadvances.2023010349. 
   

• Ghamari SH, et al. "Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial." BMJ. 2023 Sep 21;382:e070464. https://doi.org/10.1136/bmj-2023-070464. 
   

• Walsh SR, et al. "Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial." Lancet Respir Med. 2023 Sep 1 https://doi.org/10.1016/S2213-2600(23)00263-1. Published Online September 13, 2023 
   

• Walsh SR, et al. "Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study." EClinicalMedicine. 2023 Sep 12;64:102168. https://doi.org/10.1016/j.eclinm.2023.102168. eCollection 2023 Oct. 
   

• Fang Y, et al. "Chatbot-Delivered Online Intervention to Promote Seasonal Influenza Vaccination During the COVID-19 Pandemic: A Randomized Clinical Trial." JAMA Netw Open. 2023 Sep 5;6(9):e2332568. https://doi.org/10.1001/jamanetworkopen.2023.32568. (Original study) 
   

• Luo C, et al. "Stroke Following COVID-19 Vaccination: Evidence Based on Different Designs of Real-World Studies." J Infect Dis. 2023 Aug 3:jiad306. https://doi.org/10.1093/infdis/jiad306. 
   

• Chung MSH, et al. "Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study." PLoS Med. 2023 Jul 24;20(7):e1004274. https://doi.org/10.1371/journal.pmed.1004274. eCollection 2023 Jul. 
   

• Mashasi I, et al. "Factors associated with COVID-19 vaccine uptake among people with type 2 diabetes in Kenya and Tanzania: a mixed-methods study." BMJ Open 2023;13:e073668. Accepted 21 August 2023 doi: 10.1136/bmjopen-2023-073668. 
   

• Zullo AR, et al. "Comparative Risks of Potential Adverse Events Following COVID-19 mRNA Vaccination Among Older US Adults." JAMA Netw Open. 2023 Aug 1;6(8):e2326852. https://doi.org/10.1001/jamanetworkopen.2023.26852. 
   

• Duriseti R, et al. "Potential “Healthy Vaccinee Bias” in a Study of BNT162b2 Vaccine against Covid-19." July 20, 2023 N Engl J Med 2023; 389:284-286 https://doi.org/10.1056/NEJMc2306683. 
   

• Dadoun SE, et al. "Coronavirus Disease 2019 (COVID-19) Vaccination and Assisted Reproduction Outcomes: A Systematic Review and Meta-analysis." Obstet Gynecol. 2023 Jul 13. https://doi.org/10.1097/AOG.0000000000005310. 

• Zhang H, et al. "The Efficacy of SARS-CoV-2 Vaccination in the Elderly: A Systemic Review and Meta-analysis." J Gen Intern Med. 2023 Jun 2. https://doi.org/10.1007/s11606-023-08254-9. 
  
  

• Martin-Bauta Y, et al. "A phase 3, randomised, double-blind, placebo-controlled clinical trial evaluation of the efficacy and safety of a SARS-CoV-2 recombinant spike RBD protein vaccine in adults (ABDALA-3 study)." Lancet Reg Health Am. 2023 May;21:100497. https://doi.org/10.1016/j.lana.2023.100497. Epub 2023 May 5. 
   

• Wang BS, et al. "Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trial." Lancet Respir Med. 2023 Mar 7:S2213-2600(23)00049-8. https://doi.org/10.1016/S2213-2600(23)00049-8. 
   

• Alves K, et al. "Immunogenicity of a Fourth Homologous Dose of NVX-CoV2373." March 2, 2023 N Engl J Med 2023; 388:857-859 https://doi.org/10.1056/NEJMc2215509. 
   

• Duan M, et al. "Neutralization of BQ.1, BQ.1.1, and XBB with RBD-Dimer Vaccines." NEJM March 1, 2023 https://doi.org/10.1056/NEJMc2216233. 
   

• Dalvi APR, et al. "The effect of BCG vaccination on infection and antibody levels against SARS-CoV-2 - The results of ProBCG: A Multicenter Randomized Clinical Trial in Brazil." Int J Infect Dis. 2023 Feb 23:S1201-9712(23)00065-6. https://doi.org/10.1016/j.ijid.2023.02.014. 
   

• Rubin E, et al. "Audio Interview: What to Expect from Covid-19 Vaccines." February 16, 2023 N Engl J Med 2023; 388:e23 https://doi.org/10.1056/NEJMe2301645. 
   

• Ribeiro PAB, et al. "Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022." Lancet Respir Med. 2023 Feb 13 https://doi.org/10.1016/S2213-2600(23)00015-2. 
   

• Geng Y, et al. "COVID-19 vaccination in patients with cancer receiving immune checkpoint inhibitors: a systematic review and meta-analysis." J Immunother Cancer. 2023 Feb;11 (2):e006246. https://doi.org/10.1136/jitc-2022-006246. 
   

• Calabro GE, et al. "Incremental Net Benefit and Incremental Cost-Effectiveness Ratio of COVID-19 Vaccination Campaigns: Systematic Review of Cost-Effectiveness Evidence." Vaccines (Basel). 2023 Feb 3;11(2):347.  https://doi.org/10.3390/vaccines11020347. 

• Scientists claim to have solved Covid vaccine blood-clot puzzle.
• Two vaccine doses needed for strong protection against variant found in India, data show.
• Pfizer and AstraZeneca ‘highly effective’ against India Covid variant.
• The same covid-19 mutations are appearing in different places. 
• U.S. issues emergency use authorization for Johnson & Johnson's one-shot COVID-19 vaccine.
• Pfizer and BioNTech Submit COVID-19 Vaccine Stability Data at Standard Freezer Temperature to the U.S. FDA
• Isth statement on astrazeneca covid-19 vaccine and thrombosis.
• Pfizer-biontech announce positive topline results of pivotal covid-19 vaccine study in adolescents.
• NIH begins study of allergic reactions to Moderna, Pfizer-BioNTech COVID-19 vaccines.
• Michigan officials found only 246 COVID-19 cases among fully vaccinated.
• Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 April 2021.
• Pfizer COVID Vaccine Protects for 6 Months or More.
• China considers mixing COVID-19 vaccines to boost protection rate.
• Infection rate for people living with healthcare workers at least 30% lower when worker vaccinated mostly with a single dose.
• Covid vaccine: US trial of AstraZeneca jab confirms safety.
• Taking the vaccine is a necessary step to overcome #COVID19. To receive the vaccine, register your name and your family members' names on the official platform for the Ministry of Public Health. 
• COVID-19 Coronavirus Lebanon Cases - MOPH.
• The same covid-19 mutations are appearing in different places.
• Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial.
• Coronavirus Vaccine Tracker. 
• These Coronavirus Trials Don’t Answer the One Question We Need to Know.
• The looming question': Fauci says studies suggest vaccines slow virus spread.
• COVID vaccines and safety: what the research says.
• Covid-19 Vaccine Resource Center.
• Covid-19 Vaccine — Frequently Asked Questions.
• COVID-19 Vaccine: Q&A - لقاح الكورونا: أسئلة وأجوبة (video)
• Educational Material on COVID-19 Immunization. 
• Elsevier Vaccines Toolkit.
• CDC website -Vaccines for COVID-19.
• Community-Based Organizations COVID-19 Vaccination Toolkit.
• Interim Public Health Recommendations for Fully Vaccinated People.
• Key Things to Know About COVID-19 Vaccines.
• COVID-19 Vaccinations in the United States.
• Facts about COVID-19 Vaccines.

As part of K2P COVID-19 Series, K2P center is pleased to launch the latest product: “A Closer Look at COVID-19 Vaccines: The Known, the Unknown, and the Uncertain”. (Arabic Version) , (English Version) , (Full Product Version)

 This is the second product on the COVID-19 Vaccine developed by K2P. To know more about the first product, you can check at: Countdown to a COVID-19 Vaccine: Spotlight on Lebanon

Images